Fairmount Funds Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-389,588
| Closed | -$3.73M | – | 22 |
|
|
2022
Q3 | $3.73M | Hold |
389,588
| – | – | 0.66% | 23 |
|
|
2022
Q2 | $4.3M | Hold |
389,588
| – | – | 0.98% | 23 |
|
|
2022
Q1 | $6.49M | Hold |
389,588
| – | – | 1.53% | 18 |
|
|
2021
Q4 | $7.44M | Hold |
389,588
| – | – | 2.45% | 16 |
|
|
2021
Q3 | $9.61M | Sell |
389,588
-116,302
| -23% | -$2.87M | 3.49% | 12 |
|
|
2021
Q2 | $13.2M | Sell |
505,890
-60,000
| -11% | -$1.56M | 5.41% | 5 |
|
|
2021
Q1 | $17.9M | Hold |
565,890
| – | – | 7.55% | 3 |
|
|
2020
Q4 | $26.3M | Sell |
565,890
-31,000
| -5% | -$1.44M | 9.39% | 3 |
|
|
2020
Q3 | $19.7M | Sell |
596,890
-7,000
| -1% | -$230K | 8.32% | 5 |
|
|
2020
Q2 | $16.6M | Buy |
603,890
+112,500
| +23% | +$3.09M | 7.39% | 6 |
|
|
2020
Q1 | $14.7M | Buy |
491,390
+37,500
| +8% | +$1.12M | 8.92% | 4 |
|
|
2019
Q4 | $12.6M | Buy |
+453,890
| New | +$12.6M | 7.62% | 5 |
|